No Data
No Data
Lexaria Bioscience Explores Oral Liraglutide Potential
Lexaria Bioscience Engages CRO for Human Pilot Study of DehydraTEHC-liraglutide
Liraglutide Processed With DehydraTECH to Be Studied in Human GLP-1 Study #5
Insider Purchase: Chief Executive Officer of $LEXX (LEXX) Buys 22,828 Shares
Lexaria Bioscience's DehydraTECH Shows Promising Potential With Positive Study Outcomes and Strong Financial Position
BTV Features These Stocks to Watch: Contango Ore, First Nordic Metals, Champion Iron, Prime Mining, Lexaria Bioscience, Osisko Development, West Red Lake Gold Mines, & Surge Battery Metals
No Data